Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Phenotype C0040053|thrombosis
Sentences 24
PubMedID- 23914640 Conclusion: colour doppler sonognaphy is an effective, non-invasive method for evaluating the presence of portal vein thrombosis associated with hepatocellular carcinoma.
PubMedID- 23751743 And it may prolong os and ttp in hepatocellular carcinoma with tumor thrombosis in right/left portal vein and second branch of portal vein.
PubMedID- 21054520 Background and aim: we aimed to validate the non-invasive criteria for the characterization of portal vein thrombosis (pvt) in patients with cirrhosis and hepatocellular carcinoma (hcc).
PubMedID- 23267913 [a case of advanced hepatocellular carcinoma with tumor thrombosis in the main trunk of the portal vein successfully treated by multidisciplinary therapies].
PubMedID- 21110841 Portal vein tumor thrombosis (pvtt) is associated with hepatocellular carcinoma (hcc), with a reported incidence of pvtt of 30% to 70% [1-3].
PubMedID- 26011214 Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.
PubMedID- 21190093 Introduction: portal vein thrombosis is frequently associated with hepatocellular carcinoma (hcc).
PubMedID- 26152896 The aim of the study is to evaluate the practicability and therapeutic efficacy of (125)iodine seeds implantation percutaneously for portal vein tumor thrombosis (pvtt) in patients with hepatocellular carcinoma (hcc).
PubMedID- 25834310 Management of hepatocellular carcinoma (hcc) with portal vein thrombosis (pvt) is complex and requires an understanding of multiple therapeutic options.
PubMedID- 20819658 Background: few reports have evaluated the efficacy of re-operation for relapse after initial surgery for hepatocellular carcinoma (hcc) with bile duct thrombosis (bdt).
PubMedID- 22689916 Objective: to evaluate the treatment outcome of three-dimensional conformal radiotherapy in hepatocellular carcinoma patients with portal vein thrombosis, concerning survival and treatment response of thrombosis.
PubMedID- 21860551 Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.
PubMedID- 20583822 Portal vein tumor thrombosis (pvtt) in patients with hepatocellular carcinoma (hcc) is known as a major complication associated with poor survival.
PubMedID- 25502254 Eus-fna of a portal vein thrombosis in a patient with a hidden hepatocellular carcinoma: confirmation technique after contrast-enhanced ultrasound.
PubMedID- 23914915 Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib.
PubMedID- 22330617 Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report.
PubMedID- 22206054 Atypical enhancement pattern of hepatocellular carcinoma with portal vein thrombosis on multiphasic ct.
PubMedID- 22176468 Aim: we investigated the efficacy of hepatic arterial infusion chemotherapy (haic) using 5-fluorouracil (5-fu) and systemic interferon (ifn)-alpha (haic-5-fu/ifn) for advanced hepatocellular carcinoma (hcc) with venous tumor thrombosis (vtt) in the hepatic vein trunk (vv2) or inferior vena cava (vv3).
PubMedID- 20981227 Treatment of hepatocellular carcinoma with portal vein thrombosis by sorafenib combined with hepatic arterial infusion chemotherapy.
PubMedID- 24798618 Background & aims: presence of hepatic vein tumor thrombosis (hvtt) in patients with hepatocellular carcinoma (hcc) is regarded as signaling an extremely poor prognosis.
PubMedID- 21113349 Complete metabolic response with recanalization of portal vein tumor thrombosis after sunitinib in a patient with advanced hepatocellular carcinoma.
PubMedID- 25324989 Purpose: we sought to evaluate the clinical outcomes of 3-dimensional conformal radiation therapy (3d-crt) for portal vein tumor thrombosis (pvtt) alone in patients with advanced hepatocellular carcinoma.
PubMedID- 25935229 Background: the role of liver resection (lr) of hepatocellular carcinoma with macroscopic vascular thrombosis (mvt) remains controversial.
PubMedID- 25847227 Background: the safety and efficacy of yttrium 90 (90 y) therapy for unresectable infiltrative hepatocellular carcinoma (hcc) with portal vein thrombosis (pvt) requires further evaluation.

Page: 1